(Q42809124)

7 November 2017

title

Pharmacological characterization of a small molecule inhibitor of c-Jun kinase (English)

1 reference

7 November 2017

Helen Cho

1

1 reference

7 November 2017

Shawn C Black

2

1 reference

7 November 2017

David Looper

3

1 reference

7 November 2017

Manli Shi

4

1 reference

7 November 2017

Dawn Kelly-Sullivan

5

1 reference

7 November 2017

Sergei Timofeevski

6

1 reference

7 November 2017

Karen Siegel

7

1 reference

7 November 2017

Xiao-Hong Yu

8

1 reference

7 November 2017

Scott R McDonnell

9

1 reference

7 November 2017

Ping Chen

10

1 reference

7 November 2017

Junming Yie

11

1 reference

7 November 2017

Kathleen M Ogilvie

12

1 reference

7 November 2017

James Fraser

13

1 reference

7 November 2017

Celia P Briscoe

14

1 reference

7 November 2017

publication date

26 August 2008

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 November 2017

published in

1 reference

7 November 2017

volume

295

1 reference

7 November 2017

issue

5

1 reference

7 November 2017

page(s)

E1142-51

1 reference

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

The specificities of protein kinase inhibitors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Signal transduction by tumor necrosis factor mediated by JNK protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Inflammation, stress, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90298.2008

10.1152/AJPENDO.90298.2008

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference